End Allergies Together Announces Research Grants

NEW YORK, May 23, 2016 /PRNewswire/ -- End Allergies Together (E.A.T.) announces it will be funding three studies within their first year of operation.  E.A.T. is a non-profit organization whose sole mission is to support food allergy research to accelerate treatments and cures.  

E.A.T. received numerous applications to fund a wide spectrum of food allergy research.  The following three studies will be funded: 

Biomarkers
'Molecular Gene Expression During Allergic Reactions to Food:
Identifying Signatures Which Correlate with Severity of Reaction'
Jonathan M. Spergel, MD, PhD, Division of Allergy-Immunology, The Children's Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania
Paul J. Turner, FRACP PhD, Section of Pediatrics (Allergy-Immunology), Faculty of Medicine, Imperial College London, United Kingdom.

Microbiome
'Characterization of Prebiotic Dietary Fibers to Prevent or Treat Food Allergy'
Cathryn R. Nagler, Ph.D.
Bunning Food Allergy Professor, Professor of Pathology, Medicine, Pediatrics and The College, The University of Chicago

Oral Immunotherapy 
'Improving Safety for the Food Allergy-Asthma Syndrome'
Sharon Chinthrajah, MD, Kari Nadeau, MD, PhD 
Pulmonary and Critical Care Medicine, Allergy and Immunology, Sean N Parker Center for Allergy and Asthma Research, Stanford University 

"We are excited to fund an array of studies that will render results in the short-term to help us better understand crucial areas in food allergy research," commented E.A.T. co-founders Elise Bates and Kim Hall. "There were many exciting studies we could not fund at this time which only deepens our desire to raise more money for research."

Please visit www.EndAllergiesTogether.com/Research for a deeper explanation of each study. 

ABOUT END ALLERGIES TOGETHER (E.A.T) E.A.T. is a non-profit organization registered 501(c)(3) committed to finding a cure for food allergies by directly funding the researchers who strive to find solutions for this rapidly growing epidemic. E.A.T. has underwritten administrative costs so that 100% of net proceeds have gone straight to scientists. E.A.T. was founded on the premise that everyone's contribution is crucial and that together, we can End Allergies.

E.A.T.'s Medical Advisory Board is comprised of highly knowledgeable physicians and scientists who are leaders in the field but not conducting their own studies thus ensuring an objective funding allocation process.

SOURCE End Allergies Together (E.A.T)

Related Links

http://www.EndAllergiesTogether.com/Research